MPN

Susanne Isfort Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany

Comorbidities Such As Thromboembolic Events Significantly Worsen Patient-Reported Quality of Life (QoL) and Symptoms in...Lees meer

0120HEM1291431

Hematologie

ASH 2018

Andere categorieën

MPN

Afdrukken

ASH 2018 - Ruben Mesa, PhD, MPN and MF study results

Ruben Mesa, PhDRuben Mesa PhD UT Health San Antonio Cancer Center, San Antonio

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Results of Myeloproliferative Disorders...Lees meer

0120HEM1291431

Hematologie

ASH 2018

Andere categorieën

Afdrukken

ASH 2018 - Natasha Szuber, MD, MPN studies

Natasha Szuber, MD Division of Hematology, Mayo Clinic, Montreal, QC, Canada

Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

0120HEM1291431

Afdrukken

MPN Diagnosis

Prof dr. C. Harrison, UK; dr. A. Reiter Germany; Basic Learning: MPN Spotlight; accurately diagnosing MPN: a multidisciplinary perspectiveLees meer

0718HEM1089078

Hematologie

Hematalks

Andere categorieën

MPN

Afdrukken

unadequately controlled PV

Prof dr. HM. Kvasnicka, Germany; dr. A. Reiter Germany; Basic Learning: MPN Spotlight; IS your patient with PV adequately controlled with hydroxyurea?

0718HEM1089078

Afdrukken

MF symptoms

Prof dr. C. Harrison, UK; dr. A. Reiter Germany; Basic Learning: MPN Spotlight; symptoms in Myleofibrosis (MF): a closer look at the impact on morbidity and mortalityLees meer

0718HEM1089078

Hematologie

Hematalks

MPN